{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:39:02Z","timestamp":1789598342422,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was performed at the Faculty of Veterinary Medicine, Urmia University, Urmia, Iran, and was financially supported by the first author (Rusul Abdulhamid Kadhim)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-05017-y","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:17:15Z","timestamp":1759407435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Berberine ameliorates acute hyperglycemia and hypoinsulinemia induced by ketamine\/xylazine in rats: role of alpha2 adrenergic receptors, oxidative stress and inflammatory suppressing mechanisms"],"prefix":"10.1186","volume":"21","author":[{"given":"Rusul Abdulhameed","family":"Kadhim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Erfanparast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeal","family":"Tamaddonfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davoud","family":"Amirkashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Imani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"1","key":"5017_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12917-022-03193-9","volume":"18","author":"MM Abouelfetouh","year":"2022","unstructured":"Abouelfetouh MM, Salah E, Liu L, Ding M, Ding Y. Intrathecal adenosine enhances the antinociception of xylazine in goats. BMC Vet Res. 2022;18(1):105.","journal-title":"BMC Vet Res"},{"key":"5017_CR2","doi-asserted-by":"crossref","unstructured":"Flecknell P, editor. Basic Principles of Anaesthesia in: Flecknell P. Laboratory Animal Anaesthesia. 2016; fourth ed. Academic press, pp:1\u201375.","DOI":"10.1016\/B978-0-12-800036-6.00001-6"},{"issue":"10","key":"5017_CR3","first-page":"646","volume":"74","author":"A Karasu","year":"2018","unstructured":"Karasu A, Altug NURI, Aslan L, Bakir B, Y\u00fcksek N. Evaluation of the anesthetic effects of xylazine-ketamine, xylazine-tiletamine-zolazepam and tiletamine-zolazepam using clinical and laboratory parameters in rabbits. Med Weter. 2018;74(10):646\u201352.","journal-title":"Med Weter"},{"issue":"2","key":"5017_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1467-2995.2005.00243.x","volume":"33","author":"SB K\u00e4stner","year":"2006","unstructured":"K\u00e4stner SB. A2-agonists in sheep: a review. Vet Anaesth Analg. 2006;33(2):79\u201396.","journal-title":"Vet Anaesth Analg"},{"issue":"10","key":"5017_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/153537020523001012","volume":"230","author":"JK Saha","year":"2005","unstructured":"Saha JK, Xia J, Grondin JM, Engle SK, Jakubowski JA. Acute hyperglycemia induced by ketamine\/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp Biol Med (Maywood). 2005;230(10):777\u201384.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"15","key":"5017_CR6","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.3390\/ijms25158504","volume":"25","author":"M Pepe","year":"2024","unstructured":"Pepe M, Addabbo F, Cecere A, Tritto R, Napoli G, Nestola PL, Cirillo P, Biondi-Zoccai G, Giordano S, Ciccone MM. Acute hyperglycemia-induced injury in myocardial infarction. Int J Mol Sci. 2024;25(15):8504.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5017_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17925\/USE.2017.13.01.17","volume":"13","author":"ML Marcovecchio","year":"2017","unstructured":"Marcovecchio ML. Complications of acute and chronic hyperglycemia. US Endocrinol. 2017;13(1):17\u201321.","journal-title":"US Endocrinol"},{"key":"5017_CR8","doi-asserted-by":"crossref","unstructured":"Imenshahidi M, Hosseinzadeh H. Berberine neuroprotection and antioxidant activity in: Oxidative stress and dietary antioxidants in neurological diseases 2020; Academic Press. pp: 199\u2013216.","DOI":"10.1016\/B978-0-12-817780-8.00014-1"},{"key":"5017_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","volume":"761","author":"A Kumar","year":"2015","unstructured":"Kumar A, Chopra K, Mukherjee M, Pottabathini R, Dhull DK. Current knowledge and Pharmacological profile of berberine: an update. Eur J Pharmacol. 2015;761:288\u201397.","journal-title":"Eur J Pharmacol"},{"key":"5017_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fphar.2018.00557","volume":"9","author":"MA Neag","year":"2018","unstructured":"Neag MA, Mocan A, Echeverr\u00eda J, Pop RM, Bocsan CI, Cri\u015fan G, Buzoianu AD. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557.","journal-title":"Front Pharmacol"},{"key":"5017_CR11","doi-asserted-by":"crossref","unstructured":"Shrivastava S, Sharma A, Saxena N, Bhamra R, Kumar S. Addressing the preventive and therapeutic perspective of Berberine against diabetes. Heliyon. 2023;9(11):e21233.","DOI":"10.1016\/j.heliyon.2023.e21233"},{"key":"5017_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","volume":"59","author":"H Zhang","year":"2010","unstructured":"Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59:285\u201392.","journal-title":"Metabolism"},{"key":"5017_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fphar.2018.00782","volume":"9","author":"X Ma","year":"2018","unstructured":"Ma X, Chen Z, Wang L, Wang G, Wang Z, Dong X, Wen B, Zhang Z. The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its Inhibition by Berberine. Front Pharmacol. 2018;9:782.","journal-title":"Front Pharmacol"},{"issue":"3","key":"5017_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.phrs.2007.06.003","volume":"56","author":"CH Lee","year":"2007","unstructured":"Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. Berberine suppresses inflammatory agents-induced interleukin-1\u03b2 and tumor necrosis factor-\u03b1 productions via the Inhibition of I\u03baB degradation in human lung cells. Pharmacol Res. 2007;56(3):193\u2013201.","journal-title":"Pharmacol Res"},{"issue":"2","key":"5017_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.metabol.2010.02.005","volume":"60","author":"Y Wang","year":"2011","unstructured":"Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L. Hypoglycemic and insulin-sensitizing effects of Berberine in high-fat diet-and streptozotocin-induced diabetic rats. Metabolism. 2011;60(2):298\u2013305.","journal-title":"Metabolism"},{"issue":"1","key":"5017_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2253-13-33","volume":"13","author":"YF Xiao","year":"2013","unstructured":"Xiao YF, Wang B, Wang X, Fenglai D, Benzinou M, Wang YJ. Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys. BMC Anesthesiol. 2013;13(1):1\u20139.","journal-title":"BMC Anesthesiol"},{"key":"5017_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1742-7843.2011.00699.x","volume":"108","author":"V Fagerholm","year":"2011","unstructured":"Fagerholm V, Haaparanta M, Scheinin M. \u03b12- adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol. 2011;108:365\u201370.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"5017_CR18","first-page":"149","volume":"12","author":"F Safaei","year":"2021","unstructured":"Safaei F, Tamaddonfard E, Nafisi S, Imani M. Effects of intraperitoneal and intracerebroventricular injection of cinnamaldehyde and Yohimbine on blood glucose and serum insulin concentrations in ketamine-xylazine induced acute hyperglycemia. Vet Res Forum. 2021;12(2):149\u201356.","journal-title":"Vet Res Forum"},{"key":"5017_CR19","first-page":"183","volume":"8","author":"R Abdulhamid Kadhim","year":"2025","unstructured":"Abdulhamid Kadhim R, Erfanparast A, Tamaddonfard E, Amirkashani D, Imani M. Effects of Linalool on acute hyperglycemia and hypoinsilinemia induced by ketamine-xylazine in rats: the role of alpha2 adrenergic receptors. Ir J Physiol Pharmacol. 2025;8:183\u201394.","journal-title":"Ir J Physiol Pharmacol"},{"issue":"3","key":"5017_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.tvjl.2014.03.024","volume":"200","author":"L Bellini","year":"2014","unstructured":"Bellini L, Banzato T, Contiero B, Zotti A. Evaluation of three medetomidine-based protocols for chemical restraint and sedation for Non painful procedures in companion rats (Rattus norvegicus). Vet J. 2014;200(3):456\u20138.","journal-title":"Vet J"},{"issue":"2","key":"5017_CR21","first-page":"92","volume":"10","author":"C Hsu","year":"1986","unstructured":"Hsu C, Hsu HK, Lee JN, Yu JY. The influence of estrogen on the hyperglycemic action of alloxan in female rats. Proc Natl Sci Counc Repub China Part B. 1986;10(2):92\u20137.","journal-title":"Proc Natl Sci Counc Repub China Part B"},{"issue":"26","key":"5017_CR22","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/S0024-3205(01)01100-6","volume":"68","author":"S Morimoto","year":"2001","unstructured":"Morimoto S, Cerb\u00f3n MA, Alvarez-Alvarez A, Romero-Navarro G, D\u0131\u0301az-S\u00e1nchez V. Insulin gene expression pattern in rat pancreas during the estrous cycle. Life Sci. 2001;68(26):2979\u201385.","journal-title":"Life Sci"},{"issue":"6","key":"5017_CR23","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"key":"5017_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejphar.2008.05.043","volume":"589","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of Berberine chloride. Eur J Pharmacol. 2008;589:163\u201372.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5017_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/ijms21031131","volume":"21","author":"IR Ilyasov","year":"2020","unstructured":"Ilyasov IR, Beloborodov VL, Selivanova IA, Terekhov RP. ABTS\/PP decolorization assay of antioxidant capacity reaction pathways. Int J Mol Sci. 2020;21(3):1131.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5017_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469\u201374.","journal-title":"Eur J Biochem"},{"issue":"2","key":"5017_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351\u20138.","journal-title":"Anal Biochem"},{"issue":"2","key":"5017_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s43440-021-00232-4","volume":"73","author":"S Kohtala","year":"2021","unstructured":"Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and Neurobiological mechanisms. Pharmacol Rep. 2021;73(2):323\u201345.","journal-title":"Pharmacol Rep"},{"issue":"8","key":"5017_CR29","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jat\/bkac049","volume":"46","author":"SL Kacinko","year":"2022","unstructured":"Kacinko SL, Mohr AL, Logan BK, Barbieri EJ. Xylazine: Pharmacology review and prevalence and drug combinations in forensic toxicology casework. J Anal Toxicol. 2022;46(8):911\u20137.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"5017_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cmet.2009.12.002","volume":"11","author":"J Wess","year":"2010","unstructured":"Wess J. More is not always better: \u03b12A-adrenoceptor expression in type 2 diabetes. Cell Metab. 2010;11(1):3\u20135.","journal-title":"Cell Metab"},{"key":"5017_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1126\/science.1176827","volume":"327","author":"AH Rosengren","year":"2010","unstructured":"Rosengren AH, Jokubka R, Tojjar D, Granhall C, Hansson O, Li DQ, Nagaraj V, Reinbothe TM, Tuncel J, Eliasson L, Groop L. Overexpression of alpha2 aadrenergic receptors contributes to type 2 diabetes. Science. 2010;327:217\u201320.","journal-title":"Science"},{"key":"5017_CR32","first-page":"239749","volume":"20151","author":"Z Wang","year":"2015","unstructured":"Wang Z, Wu J, Zhou Q, Wang Y, Chen T. Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL\/6 mice. Evid Based Complement Altern Med. 2015;20151:239749.","journal-title":"Evid Based Complement Altern Med"},{"key":"5017_CR33","doi-asserted-by":"publisher","first-page":"12856","DOI":"10.3390\/ijms252312856","volume":"25","author":"A Nowacka","year":"2024","unstructured":"Nowacka A, \u015aniegocka M, \u015aniegocki M, Zi\u00f3\u0142kowska E, Bo\u017ci\u0142ow D, Smuczy\u0144ski W. Multifaced nature of yohimbine -A promising therapeutic potential or a risk? Int J Mol Sci. 2024;25:12856.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5017_CR34","first-page":"28","volume":"28","author":"A Erfanparast","year":"2017","unstructured":"Erfanparast A, Tamaddonfard E, Mohammadi E, Nemati S, Mohammadi R. The effect of vitamin B12 on acute model of hyperglysemia induced by ketaminexylazine in rats. Stud Med Sci. 2017;28(1):28\u201338.","journal-title":"Stud Med Sci"},{"key":"5017_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tvjl.2011.12.010","volume":"193","author":"F Restitutti","year":"2012","unstructured":"Restitutti F, Raekallio M, Vainionp\u00e4\u00e4 M, Kuusela E, Vainio O. Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: a peripheral \u03b1-2 adrenoceptor antagonist. Vet J. 2012;193:481\u20135.","journal-title":"Vet J"},{"issue":"6","key":"5017_CR36","first-page":"511","volume":"7","author":"WX Yao","year":"1986","unstructured":"Yao WX, Ling BD, Chen B, Han H, Fang DC, Jiang MX. Blocking action of Berberine on alpha 2 and alpha 1 adrenoceptors in the rat Vas deferens and anococcygeus muscle. Acta Pharmacol Sin. 1986;7(6):511\u20135.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"5017_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0024-3205(91)90019-8","volume":"49","author":"KK Hui","year":"1991","unstructured":"Hui KK, Jun LY, Chan WFA. Interaction of Berberine with human platelet \u03b12 adrenoceptors. Life Sci. 1991;49(4):315\u201324.","journal-title":"Life Sci"},{"issue":"2","key":"5017_CR38","first-page":"89","volume":"16","author":"SS Ghoreishi","year":"2025","unstructured":"Ghoreishi SS, Azizi S, Tamaddonfard E, Aghazadeh S. Thymoquinone attenuates paw incision-induced spontaneous and evoked pain through anti-oxidative and anti-inflammatory mechanisms in rats. Vet Res Forum. 2025;16(2):89\u201396.","journal-title":"Vet Res Forum"},{"issue":"8","key":"5017_CR39","first-page":"e66570","volume":"16","author":"S Sabitha","year":"2024","unstructured":"Sabitha S, Hegde SV, Agarwal SV, Delna NS, Pillai A, Shah SN, Ramjeela S, SHAH SN. Biomarkers of oxidative stress and their clinical relevance in type 2 diabetes mellitus patients: A systematic review. Cureus. 2024;16(8):e66570.","journal-title":"Cureus"},{"key":"5017_CR40","doi-asserted-by":"publisher","first-page":"110660","DOI":"10.1016\/j.biopha.2020.110660","volume":"131","author":"Y Wang","year":"2020","unstructured":"Wang Y, Che M, Xin J, Zheng Z, Li J, Zhang S. The role of IL-1\u03b2 and TNF-\u03b1 in intervertebral disc degeneration. Biomed Pharmacother. 2020;131:110660.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"5017_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/153537020122600405","volume":"226","author":"CA Mastronardi","year":"2001","unstructured":"Mastronardi CA, Yu WH, McCann SM. Comparisons of the effects of anesthesia and stress on release of tumor necrosis factor-\u03b1, leptin, and nitric oxide in adult male rats. Exp Biol Med. 2001;226(4):296\u2013300.","journal-title":"Exp Biol Med"},{"issue":"8","key":"5017_CR42","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2337\/diacare.25.8.1439","volume":"25","author":"A Ceriello","year":"2002","unstructured":"Ceriello A, Quagliaro L, Catone B, Pascon R, Piazzola M, Bais B, Marra G, Tonutti L, Taboga C, Motz E. Role of hyperglycemia in Nitrotyrosine postprandial generation. Diabetes Care. 2002;25(8):1439\u201343.","journal-title":"Diabetes Care"},{"issue":"16","key":"5017_CR43","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067\u201372.","journal-title":"Circulation"},{"issue":"7","key":"5017_CR44","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0026-0495(03)00057-X","volume":"52","author":"PR Ling","year":"2003","unstructured":"Ling PR, Mueller C, Smith RJ, Bistrian BR. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism. 2003;52(7):868\u201374.","journal-title":"Metabolism"},{"issue":"4","key":"5017_CR45","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/ptr.8077","volume":"38","author":"F Shakeri","year":"2024","unstructured":"Shakeri F, Kiani S, Rahimi G, Boskabady MH. Anti-inflammatory, antioxidant, and Immunomodulatory effects of berberis vulgaris and its constituent berberine, experimental and clinical, a review. Phytother Res. 2024;38(4):1882\u2013902.","journal-title":"Phytother Res"},{"issue":"2","key":"5017_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.abb.2008.04.022","volume":"475","author":"W Liu","year":"2008","unstructured":"Liu W, Liu P, Tao S, et al. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Arch Biochem Biophys. 2008;475(2):128\u201334.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"5017_CR47","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.apsb.2012.06.003","volume":"2","author":"J Yin","year":"2012","unstructured":"Yin J, Ye J, Jia W. Effects and mechanisms of Berberine in diabetes treatment. Acta Pharm Sin B. 2012;2(4):327\u201334.","journal-title":"Acta Pharm Sin B"},{"key":"5017_CR48","doi-asserted-by":"publisher","first-page":"982145","DOI":"10.3389\/fendo.2022.982145","volume":"13","author":"X Fang","year":"2022","unstructured":"Fang X, Wu H, Wei J, Miao R, Zhang Y, Tian J. Research progress on the Pharmacological effects of Berberine targeting mitochondria. Front Endocrinol. 2022;13:982145.","journal-title":"Front Endocrinol"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-05017-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05017-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:09:04Z","timestamp":1759410544000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-05017-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5017"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-05017-y","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols were reviewed and approved by the Veterinary Ethics Committee of the Faculty of Veterinary Medicine at Urmia University (ethical code: IR-UU-AEC-3\/81\u2009\u2212\u20096\/1\/2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"560"}}